结节性硬化症

Oct. 07, 2026
  1. Tuberous sclerosis fact sheet. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/tuberous-sclerosis-fact-sheet. Accessed Aug. 31, 2022.
  2. Notaro K, et al. Tuberous sclerosis complex: A multisystem disorder. Journal of the American Academy of Physician Assistants. 2021; doi:10.1097/01.JAA.0000733220.26720.62.
  3. Islam MP. Tuberous sclerosis complex. Seminars in Pediatric Neurology. 2021; doi:10.1016/j.spen.2021.100875.
  4. Salussolia CL, et al. Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex. Annual Review of Genomics and Human Genetics. 2019; doi:10.1146/annurev-genom-083118-015354.
  5. Uematsu M, et al. Behavioral problems and family distress in tuberous sclerosis complex. Epilepsy & Behavior. 2020; doi:10.1016/j.yebeh.2020.107321.
  6. Randle S. Tuberous sclerosis complex: Management and prognosis. https://www.uptodate.com/contents/search. Accessed Aug. 31, 2022.
  7. What is LAM? National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/lam. Accessed Sept. 1, 2022.
  8. Parents/caregivers. TSC Alliance. https://www.tscalliance.org/individuals-families/parentscaregivers/. Accessed Aug. 31, 2022.
  9. Get support now. TSC Alliance. https://www.tscalliance.org/newly-diagnosed/get-support-now/. Accessed Aug. 31, 2022.
  10. Randle S. Tuberous sclerosis complex: Genetics, clinical features, and diagnosis. https://www.uptodate.com/contents/search. Accessed Aug. 31, 2022.
  11. Medical review (expert opinion). Mayo Clinic. Oct. 25, 2022.
  12. Hyftor (prescribing information). Nobelpharma; 2022. https://hcp.hyftor.com/. Accessed Nov. 12, 2022.